Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

ABSTRACT: Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

PROVIDER: PRJNA629044 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR11637701.fastq.gz	Fastqsanger.gz
	SRR11637705.fastq.gz	Fastqsanger.gz
	SRR11637706.fastq.gz	Fastqsanger.gz
	SRR11637711.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 68

Similar Datasets

Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

Project description:Detecting and monitoring tumor clonal evolution in the setting of measurable residual disease is technically difficult due to 1) high sequencing background due to limited numbers of disease cells, 2) loss of tumor genetic material due to the need for high quality purified DNA, and 3) resource and bioinformatics intensive requirements of traditional next generation sequencing techniques. Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq), is a fast, reproducible, and cost effective amplicon based sequencing technique that does not require genomic material isolation. It can be used in the context of just a few hundred tumor cells and is easily generalization for monitoring clonal evolution in various different malignancies.

2020-08-10 | GSE149545 | GEO

Chromatium okenii LC strain:LC

Project description:Chromatium okenii LC strain:LC Genome sequencing

| PRJNA230878 | ENA

Juvenile Fluorescence

Project description:Juvenile Fluorescence Raw sequence reads

| PRJNA436185 | ENA

LC-FACSeq is a method for detecting rare clones in leukemia.

Project description:Detecting, characterizing, and monitoring rare populations of cells can increase testing sensitivity, give insight into disease mechanism, and inform clinical decision making. One area that can benefit from increased resolution is management of cancers in clinical remission but with measurable residual disease (MRD) by multicolor FACS. Detecting and monitoring genomic clonal resistance to treatment in the setting of MRD is technically difficult and resource intensive due to the limited amounts of disease cells. Here, we describe limited-cell FACS sequencing (LC-FACSeq), a reproducible, highly sensitive method of characterizing clonal evolution in rare cells relevant to different types of acute and chronic leukemias. We demonstrate the utility of LC-FACSeq for broad multigene gene panels and its application for monitoring sequential acquisition of mutations conferring therapy resistance and clonal evolution in long-term ibrutinib treatment of patients with chronic lymphocytic leukemia. This technique is generalizable for monitoring of other blood and marrow infiltrating cancers.

| S-EPMC7406301 | biostudies-literature

Lactobacillus phage Lc-Nu

Project description:Lactobacillus phage Lc-Nu overview

| PRJNA69581 | ENA

Vibrio parahaemolyticus strain:LC

Project description:Vibrio parahaemolyticus strain:LC Genome sequencing

| PRJNA940044 | ENA

Chlamydia trachomatis D-LC

Project description:Chlamydia trachomatis D-LC genome sequencing

| PRJNA48089 | ENA

Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells

Project description:Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells was performed in order to determine mechanisms of acquired resistance in the PR1 and PR2 cell lines. NRAS p.Q61K mutation identified in PR1 cells. Upregulation of wild-type EGFR signaling identified in PR2 cells.

2017-04-21 | GSE98030 | GEO

K562+mESC SORT-seq

Project description:Single cell sequencing with SORT-seq of K562 and mESC cells

| PRJEB67546 | ENA

Cerebellum of Lurcher (Lc +/-) mouse.

Project description:Analysis of gene expression in cerebellum of postnatal day 10 Lurcher (Lc +/-) mouse, compared to wild type littermate. Keywords: other

2003-03-24 | GSE352 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data